• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微转移在甲状腺乳头状癌淋巴结比率计算中的意义。

Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.

作者信息

Chang Young Woo, Kim Hwan Soo, Jung Seung Pil, Kim Hoon Yub, Lee Jae Bok, Bae Jeoung Won, Son Gil Soo

机构信息

Department of Breast Endocrine Surgery, Korea University College of Medicine, Seoul, Korea.

出版信息

Ann Surg Treat Res. 2017 Mar;92(3):117-122. doi: 10.4174/astr.2017.92.3.117. Epub 2017 Feb 24.

DOI:10.4174/astr.2017.92.3.117
PMID:28289664
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5344800/
Abstract

PURPOSE

The lymph node ratio (LNR) is an important prognostic factor in papillary thyroid carcinoma (PTC), but micrometastases in cervical lymph nodes (LNs) are not of great clinical importance. In this study, we analyzed the accuracy of prediction of the prognosis depending on whether micrometastases were included in the number of metastatic LNs when calculating LNR.

METHODS

The study included 353 PTC patients who underwent total thyroidectomy with neck LN dissection, and calculated LNR by 2 methods according to whether micrometastases were included in the number of metastatic LNs: Method 1 did not and method 2 did include. To compare the predictive values of LNR by the 2 methods, correlation coefficients and receiver operating characteristic (ROC) curves were analyzed.

RESULTS

Positive correlations were found between LNR and preablation stimulated thyroglobulin (sTg) levels in both methods, but the correlation between method 1 LNR and preablation sTg level was significantly stronger than that for method 2 (Fisher z = 1.7, P = 0.045). The areas under these 2 independent ROC curves were analyzed; the prognostic efficacy of method 1 LNR was more accurate than that of method 2 LNR, and the difference was statistically significant (P = 0.0001).

CONCLUSION

Regional recurrence of PTC can be predicted more accurately by not including micrometastases in the number of metastatic LNs when calculating LNR.

摘要

目的

淋巴结比率(LNR)是甲状腺乳头状癌(PTC)的一个重要预后因素,但颈部淋巴结(LNs)中的微转移在临床上并不具有重大意义。在本研究中,我们分析了在计算LNR时,根据微转移是否包含在转移淋巴结数量中对预后预测的准确性。

方法

该研究纳入了353例行全甲状腺切除及颈部淋巴结清扫术的PTC患者,并根据微转移是否包含在转移淋巴结数量中,通过两种方法计算LNR:方法1不包含,方法2包含。为比较两种方法计算的LNR的预测价值,分析了相关系数和受试者工作特征(ROC)曲线。

结果

两种方法计算的LNR与消融前刺激甲状腺球蛋白(sTg)水平均呈正相关,但方法1计算的LNR与消融前sTg水平的相关性显著强于方法2(Fisher z = 1.7,P = 0.045)。分析了这两条独立ROC曲线下的面积;方法1计算的LNR的预后效能比方法2计算的LNR更准确,且差异具有统计学意义(P = 0.0001)。

结论

计算LNR时,不将微转移包含在转移淋巴结数量中可更准确地预测PTC的区域复发。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c940/5344800/c3a2f969dcbb/astr-92-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c940/5344800/d4459ccbff28/astr-92-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c940/5344800/c3a2f969dcbb/astr-92-117-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c940/5344800/d4459ccbff28/astr-92-117-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/c940/5344800/c3a2f969dcbb/astr-92-117-g002.jpg

相似文献

1
Significance of micrometastases in the calculation of the lymph node ratio for papillary thyroid cancer.微转移在甲状腺乳头状癌淋巴结比率计算中的意义。
Ann Surg Treat Res. 2017 Mar;92(3):117-122. doi: 10.4174/astr.2017.92.3.117. Epub 2017 Feb 24.
2
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.消融术前刺激甲状腺球蛋白比淋巴结比率更能预测病理N1a期甲状腺乳头状癌的复发。
Int J Clin Oncol. 2016 Oct;21(5):862-868. doi: 10.1007/s10147-016-0956-2. Epub 2016 Feb 2.
3
Number of Metastatic Lymph Nodes and Ratio of Metastatic Lymph Nodes to Total Number of Retrieved Lymph Nodes Are Risk Factors for Recurrence in Patients With Clinically Node Negative Papillary Thyroid Carcinoma.转移性淋巴结数量及转移性淋巴结与所切除淋巴结总数的比值是临床淋巴结阴性的乳头状甲状腺癌患者复发的危险因素。
Clin Exp Otorhinolaryngol. 2018 Mar;11(1):58-64. doi: 10.21053/ceo.2017.00472. Epub 2017 Oct 17.
4
Lymph node ratio predicts recurrence in pediatric papillary thyroid cancer.淋巴结比率可预测儿童乳头状甲状腺癌的复发情况。
J Pediatr Surg. 2019 Jan;54(1):129-132. doi: 10.1016/j.jpedsurg.2018.10.010. Epub 2018 Oct 5.
5
Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.甲状腺乳头状癌患者预防性中央区颈清扫术后,中央区淋巴结比值是局部区域复发的重要预测指标。
Ann Surg Oncol. 2014 Jan;21(1):277-83. doi: 10.1245/s10434-013-3258-1. Epub 2013 Sep 5.
6
Combined role of lymph node ratio and serum thyroglobulin levels in predicting prognosis of papillary thyroid carcinoma.淋巴结比联合血清甲状腺球蛋白水平在预测甲状腺乳头状癌预后中的作用。
Nucl Med Commun. 2020 Aug;41(8):733-739. doi: 10.1097/MNM.0000000000001214.
7
Central Lymph Node Ratio Predicts Recurrence in Patients with N1b Papillary Thyroid Carcinoma.中央淋巴结比率可预测N1b型乳头状甲状腺癌患者的复发情况。
Cancers (Basel). 2022 Jul 28;14(15):3677. doi: 10.3390/cancers14153677.
8
Lymph Node Ratio Predicts Recurrence in Patients with Papillary Thyroid Carcinoma with Low Lymph Node Yield.淋巴结比率可预测低淋巴结转移率的乳头状甲状腺癌患者的复发情况。
Cancers (Basel). 2023 May 27;15(11):2947. doi: 10.3390/cancers15112947.
9
The Clinical Significance of Lymph Node Ratio and Ki-67 Expression in Papillary Thyroid Cancer.甲状腺乳头状癌中淋巴结比值和 Ki-67 表达的临床意义。
World J Surg. 2021 Jul;45(7):2155-2164. doi: 10.1007/s00268-021-06070-y. Epub 2021 Apr 7.
10
Prognostic value of lymph node ratio in children and adolescents with papillary thyroid cancer.淋巴结比率在儿童和青少年甲状腺乳头状癌中的预后价值。
Clin Endocrinol (Oxf). 2021 Oct;95(4):649-656. doi: 10.1111/cen.14491. Epub 2021 May 15.

引用本文的文献

1
Pathological metastatic lymph node density (ND) predicts early recurrence in papillary thyroid cancer patients after curative resection.病理性转移性淋巴结密度(ND)可预测甲状腺乳头状癌患者根治性切除术后的早期复发。
Gland Surg. 2025 May 30;14(5):897-911. doi: 10.21037/gs-2025-36. Epub 2025 May 15.
2
Prophylactic Central Compartment Dissection on the Long-Term Outcome of Advanced (N0-T3/T4) Papillary Thyroid Cancer.预防性中央区清扫术对晚期(N0-T3/T4)甲状腺乳头状癌长期预后的影响
Indian J Otolaryngol Head Neck Surg. 2024 Aug;76(4):3256-3260. doi: 10.1007/s12070-024-04660-5. Epub 2024 Apr 12.
3
Robotic thyroidectomy using gas-insufflation one-step single-port transaxillary (GOSTA) approach.

本文引用的文献

1
Optimal Cut-Off Values of Lymph Node Ratio Predicting Recurrence in Papillary Thyroid Cancer.预测甲状腺乳头状癌复发的淋巴结比率的最佳临界值
Medicine (Baltimore). 2016 Feb;95(5):e2692. doi: 10.1097/MD.0000000000002692.
2
Pre-ablation stimulated thyroglobulin is a better predictor of recurrence in pathological N1a papillary thyroid carcinoma than the lymph node ratio.消融术前刺激甲状腺球蛋白比淋巴结比率更能预测病理N1a期甲状腺乳头状癌的复发。
Int J Clin Oncol. 2016 Oct;21(5):862-868. doi: 10.1007/s10147-016-0956-2. Epub 2016 Feb 2.
3
Should central lymph node dissection be considered for all papillary thyroid microcarcinoma?
经气腹充气一步单孔经腋窝(GOSTA)入路行机器人甲状腺切除术。
Surg Endosc. 2023 Nov;37(11):8861-8870. doi: 10.1007/s00464-023-10435-w. Epub 2023 Sep 25.
4
Evaluation of Positive Predictors of Micrometastasis in Central Lymph Nodes in Patients with Papillary Thyroid Cancer; A Cross-Sectional Study.甲状腺乳头状癌患者中央淋巴结微转移阳性预测因素的评估;一项横断面研究。
Iran J Pathol. 2022 Fall;17(4):442-447. doi: 10.30699/IJP.2022.548679.2838. Epub 2022 Sep 2.
5
Oncosuppressor-Mutated Cell-Based Diagnostic Platform for Liquid Biopsy Diagnoses Benign Head and Neck Masses and Predicts Malignancy in Thyroid Nodules: Results from a Consecutive Cohort of Patients.基于抑癌基因-突变细胞的液体活检诊断平台用于诊断头颈部良性肿块并预测甲状腺结节的恶性程度:来自连续队列患者的结果
Eur Thyroid J. 2021 Jul;10(4):285-294. doi: 10.1159/000516421. Epub 2021 Jun 7.
6
Prevalence and predictor for malignancy of contralateral thyroid nodules in patients with unilateral PTMC: a systematic review and meta-analysis.单侧甲状腺微小癌患者对侧甲状腺结节的恶性患病率及预测因素:一项系统评价和荟萃分析
Endocr Connect. 2021 Jun 21;10(6):656-666. doi: 10.1530/EC-21-0164.
7
Disease-free Survival of Patients with Differentiated Thyroid Cancer: A Study from a Tertiary Center in Oman.分化型甲状腺癌患者的无病生存期:阿曼一家三级中心的研究
Oman Med J. 2021 Mar 31;36(2):e246. doi: 10.5001/omj.2021.54. eCollection 2021 Mar.
所有甲状腺微小乳头状癌都应考虑行中央区淋巴结清扫吗?
Asian J Surg. 2016 Oct;39(4):197-201. doi: 10.1016/j.asjsur.2015.02.006. Epub 2015 Apr 22.
4
Lymph node ratio of the central compartment is a significant predictor for locoregional recurrence after prophylactic central neck dissection in patients with thyroid papillary carcinoma.甲状腺乳头状癌患者预防性中央区颈清扫术后,中央区淋巴结比值是局部区域复发的重要预测指标。
Ann Surg Oncol. 2014 Jan;21(1):277-83. doi: 10.1245/s10434-013-3258-1. Epub 2013 Sep 5.
5
Axillary dissection versus no axillary dissection in patients with sentinel-node micrometastases (IBCSG 23-01): a phase 3 randomised controlled trial.腋窝清扫与前哨淋巴结微转移患者不进行腋窝清扫(IBCSG 23-01):一项 3 期随机对照试验。
Lancet Oncol. 2013 Apr;14(4):297-305. doi: 10.1016/S1470-2045(13)70035-4. Epub 2013 Mar 11.
6
Lymph node ratio predicts recurrence in papillary thyroid cancer.淋巴结比率可预测甲状腺乳头状癌的复发。
Oncologist. 2013;18(2):157-62. doi: 10.1634/theoncologist.2012-0240. Epub 2013 Jan 23.
7
Impact of lymph node ratio on survival in papillary thyroid cancer.淋巴结比率对甲状腺乳头状癌生存的影响。
Ann Surg Oncol. 2013 Jun;20(6):1906-11. doi: 10.1245/s10434-012-2802-8. Epub 2012 Dec 23.
8
The prognostic value of the metastatic lymph node ratio and maximal metastatic tumor size in pathological N1a papillary thyroid carcinoma.病理 N1a 期甲状腺乳头状癌中转移淋巴结比率和最大转移肿瘤大小的预后价值。
Eur J Endocrinol. 2013 Jan 17;168(2):219-25. doi: 10.1530/EJE-12-0744. Print 2013 Feb.
9
Predictive value of metastatic cervical lymph node ratio in papillary thyroid carcinoma recurrence.甲状腺乳头状癌颈侧区淋巴结转移率对复发的预测价值。
Head Neck. 2013 Apr;35(4):592-8. doi: 10.1002/hed.23047. Epub 2012 Jun 23.
10
Investigation of the prognosis of patients with papillary thyroid carcinoma by tumor size.研究肿瘤大小对甲状腺乳头状癌患者预后的影响。
Endocr J. 2012;59(6):457-64. doi: 10.1507/endocrj.ej12-0013. Epub 2012 Mar 8.